Milan, Italy

Marina Mauro


Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 1996-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Marina Mauro

Introduction

Marina Mauro is a distinguished inventor based in Milan, Italy. She has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. Her work focuses on the development of innovative compounds and processes that have the potential to enhance medical treatments.

Latest Patents

Marina Mauro's latest patents include groundbreaking inventions such as the 17-aryl and 17-heterocyclyl-14.beta.-5.alpha.-androstane, androstene and - 17-Aryl -5.alpha.,14.beta.-androstane, androstene and androstadiene derivatives. These compounds are characterized by a specific formula that includes various configurations and substituents, showcasing her expertise in chemical synthesis. Additionally, she has developed a process for the crystallization from water of S-N,N'-bis(2-hydroxy-1(hydroxymethyl)ethyl)-5-(2-hydroxy-1-oxopropyl)amino-2,4,6-triiodo-1,3-benzendicarboxamide, known as Iopamidol. This process allows for the production of crystalline anhydrous Iopamidol that meets pharmacopeia standards.

Career Highlights

Throughout her career, Marina has worked with notable companies in the pharmaceutical industry, including Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. and Bracco International Bv. Her experience in these organizations has contributed to her development as a leading inventor in her field.

Collaborations

Marina has collaborated with esteemed colleagues such as Piero Melloni and Luigi Bernardi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Marina Mauro's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as a significant inventor. Her innovative work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…